Pfizer
Jennifer Hill has over 20 years of work experience in the pharmaceutical industry. Jennifer is currently working at Pfizer as the Director of Clinical Study Team Lead. Prior to that, they held various positions at Endo Pharmaceuticals, including Associate Director of Clinical Data Informatics and Analytics, and Associate Director of Clinical Operations. Before joining Endo Pharmaceuticals, Jennifer worked at Paratek Pharmaceuticals as an Associate Director of Clinical Operations. Jennifer also has experience at Wyeth as a Global Trial Leader and Clinical Scientist, at PPD as a Clinical Research Associate, and at Kendle International Inc as a Clinical Trial Support Specialist.
Jennifer Hill received their Bachelor of Science degree in Biology, with a focus on General Biology, from Bucknell University. Jennifer attended from 1997 to 2001.
This person is not in the org chart
This person is not in any offices
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.